Adrean Sean D, Chaili Siyang, Pirouz Ash, Grant Scott
Retina Consultants of Orange County, Fullerton, CA 92835, USA.
Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Clin Ophthalmol. 2020 Nov 25;14:4073-4078. doi: 10.2147/OPTH.S279845. eCollection 2020.
To describe elderly patients with central serous chorioretinopathy (CSCR) mimicking occult neovascular age-related macular degeneration (nAMD).
The records of 522 patients with initial diagnoses of nAMD over one year were reviewed to determine characteristics meeting diagnostic criteria for CSCR with three or more months of follow-up. Patients were evaluated by clinical examination, fluorescein angiography (FA) and optical coherence tomography (OCT). At the time of initial evaluation, patients were either monitored, treated with anti-VEGF therapy or with combination anti-VEGF and photodynamic therapy (PDT). When no response to anti-vascular endothelial growth factor (anti-VEGF) treatment was observed, the diagnosis of CSCR was favored and patients were observed with close follow-up. The Student's -test was used for statistical analysis; a p-value < 0.05 was considered statistically significant.
Eleven elderly patients met diagnostic criteria for CSCR among 522 patients initially diagnosed with nAMD. Average age was 75.9 years, and average follow-up was 16.9 months. Average presenting visual acuity was 20/50+2 (67.9 ± 5.9 ETDRS letters), and choroidal thickness was 232.0 ± 69.4 µm. After observation or treatment, the average vision improved to 20/40+ (70.5 ± 7.8 ETDRS letters, p=0.289). When intravitreal bevacizumab was given, no changes were observed for patients' neurosensory retinal detachments (NSRD). When NSRD changes were observed, they likewise did not correlate to the timing of anti-VEGF treatment. For patients who were monitored alone, one patient lost one line of vision, one gained one line, one gained two lines, and one gained three lines. One patient subsequently developed a choroidal neovascular membrane (CNVM) during initial follow-up with visual improvement after anti-VEGF treatment. Four patients developed CNVM overall with long term follow-up.
CSCR in elderly patients can mimic occult CNVM, especially on FA. In this group, many patients were monitored without treatment, which typically resulted in stable or improved vision. Careful monitoring is required because of possible development of CNVM.
描述表现为隐匿性新生血管性年龄相关性黄斑变性(nAMD)的老年中心性浆液性脉络膜视网膜病变(CSCR)患者。
回顾522例初诊为nAMD且随访超过一年患者的记录,以确定符合CSCR诊断标准且随访三个月以上患者的特征。通过临床检查、荧光素血管造影(FA)和光学相干断层扫描(OCT)对患者进行评估。在初始评估时,对患者进行监测、抗血管内皮生长因子(VEGF)治疗或抗VEGF与光动力疗法(PDT)联合治疗。当观察到抗血管内皮生长因子(抗VEGF)治疗无反应时,则倾向于诊断为CSCR,并对患者进行密切随访观察。采用Student's -检验进行统计分析;p值<0.05被认为具有统计学意义。
在522例初诊为nAMD的患者中,11例老年患者符合CSCR诊断标准。平均年龄为75.9岁,平均随访时间为16.9个月。初始视力平均为20/50+2(67.9±5.9 ETDRS字母),脉络膜厚度为232.0±69.4 µm。观察或治疗后,平均视力提高到20/40+(70.5±7.8 ETDRS字母,p = 0.289)。给予玻璃体内注射贝伐单抗时,患者的神经感觉视网膜脱离(NSRD)无变化。当观察到NSRD有变化时,其同样与抗VEGF治疗时间无关。对于仅接受监测的患者,1例患者视力下降一行,1例提高一行,1例提高两行,1例提高三行。1例患者在初始随访期间随后发生脉络膜新生血管膜(CNVM),抗VEGF治疗后视力改善。长期随访中共有4例患者发生CNVM。
老年患者的CSCR可类似隐匿性CNVM,尤其是在FA上。在该组中,许多患者未接受治疗而仅进行监测,这通常导致视力稳定或改善。由于可能发生CNVM,需要仔细监测。